At the forefront of driving the mesenchymal stem cells market is growing clinical application of mesenchymal stem cells for the treatment of chronic disease, autoimmune diseases, and bone and cartilage diseases. Studies reveal that mesenchymal stem cells enhance angiogenesis in myocardium and helps reduce myocardial fibrotic area. Clinical studies underway for using mesenchymal stem cells for the treatment of cardiovascular diseases, cancer, and liver diseases are projected to open new opportunities for mesenchymal stem cells.
Increasing use of mesenchymal stem cells for the treatment of diseases and disabilities of growing aging population is also having a positive influence on the global market for mesenchymal stem cells. Mesenchymal stem cells are adult stem cells that are of various types such as monocytes, osteocytes, adipocytes, and chondrocytes. Their main function is to replace or repair damaged tissue. Structurally, mesenchymal stem cells have long thin bodies with a large nucleus and have enormous capacity to regenerate. These virtues impart immense therapeutic and tissue repair ability to mesenchymal stem cells.
Request Brochure for Detailed Analysis @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=26735
Mesenchymal stem cells can differentiate into a number of cell types of skeletal tissues that include bone, fat, and cartilage. This has led to research if mesenchymal stem cells can be used to treat bone and cartilage diseases. The possibility if mesenchymal stem cells can differentiate into other types of cells such as liver cells, endothelial cells, heart muscle cells, and nerve cells is also being explored. This will further boost the mesenchymal stem cells market.